Taysha Gene Therapies
TSHA
#5776
Rank
NZ$2.21 B
Marketcap
NZ$6.80
Share price
-1.33%
Change (1 day)
-5.17%
Change (1 year)

Taysha Gene Therapies (TSHA) - P/B ratio

P/B ratio as of November 2026 : 3.17

According to Taysha Gene Therapies's latest financial reports the company has a price-to-book ratio of 223.803.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

Taysha Gene Therapies - P/B ratio (from 2020 to 2024)

P/B ratio by year

Year P/B ratio Change
2024-12-31N/A-100%
2023-12-314.42-97.03%
2022-12-311493064.46%
2021-12-314.7017.83%
2020-12-313.99

P/B ratio for similar companies or competitors

Company P/B ratio P/B ratio differencediff. Country
ORIC Pharmaceuticals
ORIC
2.02-36.27%๐Ÿ‡บ๐Ÿ‡ธ USA